Stocks News

LAST PRICE
319.3100
TODAY'S CHANGE (%)
Trending Up1.1600 (0.3646%)

Bid / Lots
316.2200/ 8
Ask / Lots
319.3100/ 4
Open / Previous Close
319.2300 / 318.1500
Day Range
Low 318.3968
High 326.1200
52 Week Range
Low 218.4400
High 329.7200
Volume
3,427,667
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ Amgen on Track for Record High Close -- Data Talk, from 9 hours ago by Dow Jones
  9 hours ago by Dow Jones
  Companies Mentioned: AMGN
  
  Amgen Inc. (AMGN) is currently at $325.55, up $7.40 or 2.33%
  
  --Would be new all-time high (Based on available data back to June 17, 1983)
  
  --Would be first new record closing high since Feb. 1, 2024, when it closed at $324.56
Jun 20, 2024
- Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033, from 8:45AM ET on Thursday Jun 20, 2024 by Dow Jones
  8:45AM ET on Thursday Jun 20, 2024 by Dow Jones
  Companies Mentioned: GILD, ONC, ONCY, RHHBY, AMGN, KYMR
  
  Amgen (NASDAQ: AMGN) recently announced the U.S. Food and Drug Administration (FDA) has approved BLINCYTO(R) (blinatumomab) for the treatment of adult and pediatric patients one month or older with CD19-positive Philadelphiachromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in the consolidation phase, regardless of measurable residual disease (MRD) status.
Jun 19, 2024
- DJ M&A Is Back. 4 Stocks That Could Be Targets. -- Barrons.com, from 1:30AM ET on Wednesday Jun 19, 2024 by Dow Jones
  1:30AM ET on Wednesday Jun 19, 2024 by Dow Jones
  Companies Mentioned: MSFT, ADBE, AMGN, BMY, CRM
  
  By Jacob Sonenshine
  
  Mergers are back -- and that means opportunity for small-cap investors.
  
  Small-caps don't have a lot going for them. The Russell 2000 index has gained 0.2% this year, lagging the S&P 500's 15% return. But they do have one thing in their favor: This year, there has been $847 billion of merger and acquisition activity in the Americas, up 43% over the same period last year, according to LSEG Group. That puts activity on pace to hit just over $1.87 trillion for the entire year, only a few hundred billion dollars below the 2021 peak. And small-cap companies are usually the target.
Jun 14, 2024
- Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer, from 4:43PM ET on Friday Jun 14, 2024 by MT Newswires
  4:43PM ET on Friday Jun 14, 2024 by MT Newswires
  Companies Mentioned: AMGN
  04:43 PM EDT, 06/14/2024 (MT Newswires) -- Amgen (AMGN) said late Friday the US Food and Drug Administration has cleared Blincyto to treat adults and children one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor ac...
- DJ Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto, from 4:43PM ET on Friday Jun 14, 2024 by Dow Jones
  4:43PM ET on Friday Jun 14, 2024 by Dow Jones
  Companies Mentioned: AMGN
  
  By Sabela Ojea
  
  Amgen said the Food and Drug Administration has approved Blincyto to treat an aggressive type of blood cancer.
  
  The biotechnology company on Friday said the approval is aimed at adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

Today
- European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading, from 8 hours ago by MT Newswires
  8 hours ago by MT Newswires
  Companies Mentioned: NVO, PHG, IHG, TEF, TRIB, GRFS, VRNA, AMRN, AKTX, AZN, EVAX, TCBP, DBVT, ASND, CUK, EDAP
- AstraZeneca Says Imfinzi With Chemotherapy Improves Survival in Phase 3 Bladder Cancer Trial, from 12 hours ago by MT Newswires
  12 hours ago by MT Newswires
  Companies Mentioned: AZN
- AstraZeneca's Tagrisso Approved With Chemotherapy in Japan for Lung Cancer Treatment, from 12 hours ago by MT Newswires
  12 hours ago by MT Newswires
  Companies Mentioned: AZN
- AstraZeneca Says Phase 3 Imfinzi Trial in Early-Stage Lung Cancer Misses Primary Endpoint, from 12 hours ago by MT Newswires
  12 hours ago by MT Newswires
  Companies Mentioned: AZN
- IMFINZI(R) (durvalumab) demonstrated statistically significant and clinically meaningful improvement in event-free survival and overall survival for muscle-invasive bladder cancer in NIAGARA Phase III trial, from 12 hours ago by Business Wire
  12 hours ago by Business Wire
  Companies Mentioned: AZN
Yesterday
- Jefferies Adjusts Price Target on Gilead Sciences to $85 From $80, from 6:25AM ET on Monday Jun 24, 2024 by MT Newswires
  6:25AM ET on Monday Jun 24, 2024 by MT Newswires
  Companies Mentioned: GILD
Jun 21, 2024
- European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher, from 11:23AM ET on Friday Jun 21, 2024 by MT Newswires
  11:23AM ET on Friday Jun 21, 2024 by MT Newswires
  Companies Mentioned: BBVA, TRIB, WPP, SQNS, TRVG, AUTL, GNFT, AKTX, MREO, AZN, BCS, SLN, EVAX, ASND, CLLS, SAN
- Nvidia Slide Stifles US Equity Futures Pre-Bell, from 8:50AM ET on Friday Jun 21, 2024 by MT Newswires
  8:50AM ET on Friday Jun 21, 2024 by MT Newswires
  Companies Mentioned: GILD, MSFT, NVDA, SRPT, ABL
- Top Premarket Gainers, from 7:34AM ET on Friday Jun 21, 2024 by MT Newswires
  7:34AM ET on Friday Jun 21, 2024 by MT Newswires
  Companies Mentioned: GILD, SLDB, SRPT, BRNS
Jun 20, 2024
- Equity Markets Close Mixed as Investors Weigh Economic Data, from 4:57PM ET on Thursday Jun 20, 2024 by MT Newswires
  4:57PM ET on Thursday Jun 20, 2024 by MT Newswires
  Companies Mentioned: GILD, JBL, ACN

Amgen Inc
NASDAQ:AMGNUnited States

Search Criteria

Today

DJ Amgen on Track for Record High Close -- Data Talk, from 9 hours ago by Dow Jones

Jun 20, 2024

Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033, from 8:45AM ET on Thursday Jun 20, 2024 by Dow Jones

Jun 19, 2024

DJ M&A Is Back. 4 Stocks That Could Be Targets. -- Barrons.com, from 1:30AM ET on Wednesday Jun 19, 2024 by Dow Jones

Jun 14, 2024

Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer, from 4:43PM ET on Friday Jun 14, 2024 by MT Newswires

DJ Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto, from 4:43PM ET on Friday Jun 14, 2024 by Dow Jones

Peers Headlines

Today

European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading, from 8 hours ago by MT Newswires

AstraZeneca Says Imfinzi With Chemotherapy Improves Survival in Phase 3 Bladder Cancer Trial, from 12 hours ago by MT Newswires

AstraZeneca's Tagrisso Approved With Chemotherapy in Japan for Lung Cancer Treatment, from 12 hours ago by MT Newswires

AstraZeneca Says Phase 3 Imfinzi Trial in Early-Stage Lung Cancer Misses Primary Endpoint, from 12 hours ago by MT Newswires

IMFINZI(R) (durvalumab) demonstrated statistically significant and clinically meaningful improvement in event-free survival and overall survival for muscle-invasive bladder cancer in NIAGARA Phase III trial, from 12 hours ago by Business Wire

Yesterday

Jefferies Adjusts Price Target on Gilead Sciences to $85 From $80, from 6:25AM ET on Monday Jun 24, 2024 by MT Newswires

Jun 21, 2024

European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher, from 11:23AM ET on Friday Jun 21, 2024 by MT Newswires

Nvidia Slide Stifles US Equity Futures Pre-Bell, from 8:50AM ET on Friday Jun 21, 2024 by MT Newswires

Top Premarket Gainers, from 7:34AM ET on Friday Jun 21, 2024 by MT Newswires

Jun 20, 2024

Equity Markets Close Mixed as Investors Weigh Economic Data, from 4:57PM ET on Thursday Jun 20, 2024 by MT Newswires